Pharmaceuticals, Biotechnology and Life Sciences
Case Study Based Review of Companion Diagnostic (CDx) Capabilities and Importance of Monitoring KRAS mutations BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. today…
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate Development and…
NEW YORK–(BUSINESS WIRE)–$BMY–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…
DUBLIN–(BUSINESS WIRE)–The “Analysis of the Global Pharmaceutical Functional and Multifunctional Excipients Market, Forecast to 2023” report has been added to…
Amryt said that Scheme has been sanctioned by the High Court of Justice in England and Wales and the Scheme Court Order is expected to be filed with the Registrar of Companies on 24 September 2019, at which point the Scheme will become effective.
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Next Generation Sequencing Market to 2027 – Regional Analysis and Forecasts by Product; Service; Application; &…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced its support…
Cerevel’s study of Tavapadon results demonstrated a statistically significant improvement in motor symptoms with once-daily dosing of oral tavapadon, which has enabled the company to plan on kicking off Phase 3 trials of tavapadon to fully characterize its potential benefit for patients with Parkinson’s disease.
International Liver Cancer Association (ILCA) is devoted exclusively to liver cancer research A Phase III study protocol for Namodenoson in…